Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy

Figure 1 Liver ECT scan. Arrow: The site where P³²-GMS was implanted.

Figure 2 P³² Radioactivity in liver of the patients with P³²-GMS (n/min). The radio activity of P³²-GMS decreased on POD 7 and POD 14 as compared with POD 1. (POD = postoperative day).

Figure 3 Radioactivity in blood and urine of the patients with P³²-GMS (n/mL/min). The radio activity in blood and urine were low. It was familiar with the sample without P³²-GMS implanted (d 0).

Figure 4 CT scan of the HCC patient who underwent hepatectomy and P³²-GMS treatments in 4 years following-up. A: Liver CT scan showing a progressive liver tumor prior to hepatectomy; B: Liver CT scan after hepatectomy; C: Liver CT scan at first postoperative year; D: Liver CT at second postoperative year; E: Liver CT at third postoperative year; F: Liver CT at fourth postoperative year. Arrows: implanted P³²-GMS.